- Home
- Signaling Pathways
- Others
- Others
- Ranolazine
Ranolazine
Catalog No.
A8510
Anti-ischemic
Featured Products
Ranolazine is an anti-ischemic which inhibits late sodium current that results in a reduction of Na+ dependent Ca2+ overload. Studies indicate that ATP production is shifted towards glucose oxidation by Ranolazine. This is due to the fact that more oxygen is required to phosphorylate the same amount of ATP during fatty acid oxidation than carbohydrate oxidation. These studies indicate that Ranolazine also inhibits oxygen consumption and ketogenesis by fatty acids in liver cells.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 427.54 |
Cas No. | 95635-55-5 |
Formula | C24H33N3O4 |
Solubility | insoluble in H2O; ≥13.18 mg/mL in EtOH with ultrasonic; ≥17.4 mg/mL in DMSO |
Chemical Name | N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide |
SDF | Download SDF |
Canonical SMILES | CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch: